Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

FDA grants tentative approval for RIFAXIMIN from CIPLA LTD

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 23
  • 0 comments

Tentative approval of ANDA #ANDA #219570 for RIFAXIMIN. Decision date: 12/08/2025

Comment Full text

FDA approves LINEZOLID from CAPLIN

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 24
  • 0 comments

Final approval of ANDA #ANDA #219558 for LINEZOLID. Decision date: 12/08/2025

Comment Full text

FDA regulatory update for ETICOVO

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 18
  • 0 comments

Administrative update #SUPPL-6 for SAMSUNG BIOEPIS CO LTD. Status: Approval. Decision date: 12/05/2025

Comment Full text

FDA updates labeling for IMITREX

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 20
  • 0 comments

Labeling changes approved for GLAXOSMITHKLINE. Active ingredient: SUMATRIPTAN SUCCINATE. Decision date: 12/09/2025

Comment Full text

FDA updates labeling for IMITREX

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 21
  • 0 comments

Labeling changes approved for GLAXOSMITHKLINE. Active ingredient: SUMATRIPTAN SUCCINATE. Decision date: 12/09/2025

Comment Full text

FDA updates labeling for IMITREX

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 20
  • 0 comments

Labeling changes approved for GLAXOSMITHKLINE. Active ingredient: SUMATRIPTAN. Decision date: 12/09/2025

Comment Full text

FDA updates labeling for OXYCODONE HYDROCHLORIDE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 18
  • 0 comments

Labeling changes approved for HIKMA. Active ingredient: OXYCODONE HYDROCHLORIDE. Decision date: 12/09/2025

Comment Full text

FDA regulatory update for WINREVAIR

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 19
  • 0 comments

Administrative update #SUPPL-8 for MERCK SHARP DOHME. Status: Approval. Decision date: 12/08/2025

Comment Full text

FDA updates labeling for RIFATER

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 14
  • 0 comments

Labeling changes approved for SANOFI AVENTIS US. Active ingredient: ISONIAZID; PYRAZINAMIDE; RIFAMPIN. Decision date: 12/05/2025

Comment Full text

FDA updates labeling for OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 15
  • 0 comments

Labeling changes approved for PH HEALTH. Active ingredient: ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE. Decision date: 12/05/2025

Comment Full text
  • Previous
  • 40
  • 41
  • 42
  • 43
  • 44
  • Next

Search

News categories

  • Technical Exchange News(11279)
  • Event(2616)
  • SEC News(198392)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(131580)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin